Molecular analyses of thyroid tumors for diagnosis of malignancy on fine-needle aspiration biopsies and for prognosis of invasiveness on surgical specimens;Analyses moléculaires des tumeurs thyroïdiennes pour le diagnostic de malignité sur matériel de cytoponction à l'aiguille fine et pour le pronostic d'invasivité sur pièces opératoires

Annales d'Endocrinologie

Volumn 72, Issue 2, 2011, Pages 125-128

  Rousset, B ^a   Ziercher, L ^a   Borson Chazot, F ^b  

^a CENTRE LÉON BÉRARD   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Fine needle aspiration biopsy; Invasiveness; Metastatic potential; Molecular diagnosis; Pan genomic transcript analyses; Papillary thyroid cancer; Thyroid cancer

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; VALINE;

ARTICLE; ASPIRATION BIOPSY; CANCER INVASION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISTANT METASTASIS; EARLY DIAGNOSIS; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC SCREENING; GENOMICS; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; PROSPECTIVE STUDY; RET GENE; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CHILD; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTORS, G-PROTEIN-COUPLED; THYROID NEOPLASMS; YOUNG ADULT;

EID: 79955718324     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2011.03.017     Document Type: Article

References (27)

1. Huang Y., Prasad M., Lemon W.J., Hampel H., Wright F.A., Kornacker K., et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A 2001, 98:15044-15049.
2. Barden C.B., Shister K.W., Zhu B., Guiter G., Greenblatt D.Y., Zeiger M.A., et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 2003, 9:1792-1800.
3. Aldred M.A., Huang Y., Liyanarachchi S., Pellegata N.S., Gimm O., Jhiang S., et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 2004, 22:3531-3539.
4. Chevillard S., Ugolin N., Vielh P., Ory K., Levalois C., Elliott D., et al. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 2004, 10:6586-6597.
5. Finley D.J., Arora N., Zhu B., Gallagher L., Fahey T.J.3rd. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. J Clin Endocrinol Metab 2004, 89:3214-3223.
6. Mazzanti C., Zeiger M.A., Costouros N.G., Umbricht C., Westra W.H., Smith D., et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 2004, 64:2898-2903.
7. Cerutti J.M., Delcelo R., Amadei M.J., Nakabashi C., Maciel R.M., Peterson B., et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 2004, 113:1234-1242.
8. Jarzab B., Wiench M., Fujarewicz K., Simek K., Jarzab M., Oczko-Wojciechowska M., et al. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Cancer Res 2005, 65:1587-1597.
9. Taniguchi K., Takano T., Miyauchi A., Koizumi K., Ito Y., Takamura Y., et al. Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction. Oncology 2005, 69:428-435.
10. Weber F., Shen L., Aldred M.A., Morrison C.D., Frilling A., Saji M., et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005, 90:2512-2521.
11. Lubitz C.C., Ugras S.K., Kazam J.J., Zhu B., Scognamiglio T., Chen Y.T., et al. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagn 2006, 8:490-498.
12. Zhao J., Leonard C., Brunner E., Gemsenjager E., Heitz P.U., Odermatt B. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. Int J Oncol 2006, 29:1041-1051.
13. Fryknas M., Wickenberg-Bolin U., Goransson H., Gustafsson M.G., Foukakis T., Lee J.J., et al. Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biol 2006, 27:211-220.
14. Stolf B.S., Santos M.M., Simao D.F., Diaz J.P., Cristo E.B., Hirata R., et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Cancer 2006, 106:1891-1900.
15. Durand S., Ferraro-Peyret C., Selmi-Ruby S., Paulin C., El Atifi M., Berger F., et al. Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. J Clin Endocrinol Metab 2008, 93:1195-1202.
16. Eszlinger M., Paschke R. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol 2010, 322:29-37.
17. Moses W., Weng J., Sansano I., Peng M., Khanafshar E., Ljung B.-M., et al. Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine-needle Aspiration Biopsy. World J Surg 2010, 34:2589-2594.
18. Xing M., Clark D., Guan H., Ji M., Dackiw A., Carson K.A., et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009, 27:2977-2982.
19. Nikiforova M.N., Nikiforov Y.E. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009, 19:1351-1361.
20. Kim S.W., Lee J.I., Kim J.W., Ki C.S., Oh Y.L., Choi Y.L., et al. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab 2010, 95:3693-3700.
21. Cerutti J.M., Oler G., Michaluart P., Delcelo R., Beaty R.M., Shoemaker J., et al. Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis. Cancer Res 2007, 67:7885-7889.
22. Vasko V., Espinosa A.V., Scouten W., He H., Auer H., Liyanarachchi S., et al. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U.S.A. 2007, 104:2803-2808.
23. Ringel M.D. Molecular markers of aggressiveness of thyroid cancer. Curr Opin Endocrinol Diabetes Obes 2009, 16:361-366.
24. Durand S., Ferraro-Peyret C., Joufre M., Chave A., Borson-Chazot F., Selmi-Ruby S., et al. Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features. Endocr Relat Cancer 2009, 16:467-481.
25. Basolo F., Torregrossa L., Giannini R., Miccoli M., Lupi C., Sensi E., et al. Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab 2010, 95:4197-4205.
26. O'Neill C.J., Bullock M., Chou A., Sidhu S.B., Delbridge L.W., Robinson B.G., et al. BRAF (V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 2010, 148:1139-1145.
27. Xing M. Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 2010, 321:86-93.